EGFR and non-small cell lung carcinoma: Therefore, we conducted a large-scale, nationwide, population-based study by using the National Health Insurance Research Database (NHIRD) to investigate the prognostic role of COPD in metastatic NSCLC patients receiving EGFR-TKI.